Received: 24 April 2018
Accepted: 26 March 2019
First Online: 5 April 2019
Ethics approval and consent to participate
: Barwon Health Human Research Ethics Committee, Geelong, Australia approved the study and its protocol (reference 15/15). The Ethics Committee will be notified of any adverse events relating to the study or any changes to the study protocol. Senior members of the organisation’s orthopaedic department will review any adverse events related to the study. The study complies with the National Statement on Ethical Conduct in Research [CitationRef removed]. All participants will provide informed written consent to participate.
: Not applicable.
: RSP receives institutional educational support from De Puy Synthes, New Brunswick, New Jersey, United States. SLM, KE, GB, SB, FC and SDG report no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.